Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $5.49B | $61.77 | $55.33 | -10.42% | Buy | 6 | 70.50% | 211.02% | 615.85% | 166.53% | |||
| SLNO | SOLENO THERAPEUTICS INC | $2.76B | $53.01 | $58.40 | 10.17% | Hold | 5 | 60.69% | 89.09% | 99.09% | 80.75% | |||
| CORT | CORCEPT THERAPEUTICS INC | $6.34B | $59.06 | $86.25 | 46.04% | Strong Buy | 4 | 28.92% | 106.23% | 105.21% | 82.37% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $39.85B | $298.48 | $438.47 | 46.90% | Strong Buy | 15 | 28.37% | 48.62% | 250.29% | 52.47% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.18B | $68.98 | $88.60 | 28.44% | Strong Buy | 5 | 13.88% | 55.21% | 522.75% | 42.96% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.90B | $302.05 | $324.11 | 7.30% | Strong Buy | 9 | 28.50% | 21.05% | 59.74% | 54.60% | |||
| ADMA | ADMA BIOLOGICS INC | $1.98B | $8.56 | $19.00 | 121.96% | Strong Buy | 2 | 20.08% | 29.54% | 130.22% | 76.41% | |||
| VCEL | VERICEL CORP | $1.81B | $35.40 | $53.00 | 49.72% | Strong Buy | 2 | 16.37% | 47.55% | 22.37% | 16.41% | |||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.08B | $6.23 | $9.50 | 52.49% | Strong Buy | 2 | 20.80% | 104.39% | N/A | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $30.55B | $53.06 | $57.80 | 8.93% | Strong Buy | 5 | 15.14% | 46.46% | 41.61% | 20.87% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $9.70B | $50.20 | $87.33 | 73.97% | Strong Buy | 18 | 15.12% | 71.12% | 28.22% | 20.41% | |||
| OMER | OMEROS CORP | $896.01M | $12.38 | $38.00 | 206.95% | Strong Buy | 2 | 261.87% | 19.86% | -598.74% | 132.51% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $605.34M | $10.24 | $24.00 | 134.38% | Strong Buy | 2 | 36.34% | 7.93% | 94.34% | 69.70% | |||
| ASND | ASCENDIS PHARMA A | $14.99B | $241.34 | $302.55 | 25.36% | Strong Buy | 11 | 34.78% | 10.74% | 263.27% | 64.13% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.00B | $239.01 | $251.09 | 5.05% | Strong Buy | 11 | 6.08% | 292.98% | 42.87% | 16.38% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.18B | $54.28 | $62.20 | 14.59% | Strong Buy | 5 | 18.67% | 32.59% | 39.09% | 28.69% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $4.36B | $217.75 | $264.00 | 21.24% | Strong Buy | 6 | 17.04% | 20.37% | 23.06% | 15.01% | |||
| SPRO | SPERO THERAPEUTICS INC | $152.28M | $2.63 | N/A | N/A | N/A | N/A | -21.95% | 47.53% | N/A | N/A | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.82B | $31.38 | $41.33 | 31.72% | Hold | 6 | 13.23% | 26.50% | 20.85% | 14.92% | |||
| TECH | BIO-TECHNE CORP | $7.31B | $46.70 | $64.83 | 38.83% | Buy | 6 | 5.02% | 48.81% | 18.99% | 15.53% | |||
| TGTX | TG THERAPEUTICS INC | $6.09B | $39.76 | $51.67 | 29.95% | Buy | 3 | 32.15% | 1.53% | 72.57% | 27.68% | |||
| EXEL | EXELIXIS INC | $12.54B | $49.90 | $48.00 | -3.81% | Buy | 7 | 11.64% | 13.74% | 65.72% | 49.05% | |||
| UTHR | UNITED THERAPEUTICS CORP | $23.94B | $563.93 | $648.22 | 14.95% | Strong Buy | 9 | 11.62% | 9.46% | 35.58% | 31.27% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $298.67M | $3.75 | $10.50 | 180.00% | Strong Buy | 2 | 15.52% | 16.46% | 41.44% | 29.84% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.82B | $31.25 | $31.50 | 0.80% | Hold | 1 | 9.44% | 8.81% | 57.07% | 50.36% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $109.25B | $430.44 | $556.47 | 29.28% | Strong Buy | 19 | 9.79% | 14.01% | 38.89% | 28.43% | |||
| VCYT | VERACYTE INC | $3.61B | $45.19 | $44.83 | -0.79% | Buy | 6 | 10.67% | 17.40% | 12.27% | 11.48% | |||
| MDXG | MIMEDX GROUP INC | $564.50M | $3.79 | $8.20 | 116.36% | Strong Buy | 5 | -3.90% | 6.45% | 22.51% | 17.72% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $161.95M | $2.01 | $12.00 | 497.01% | Buy | 1 | -5.52% | 14.32% | 13.31% | 8.75% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $68.12B | $649.76 | $824.25 | 26.85% | Buy | 20 | 9.59% | 15.29% | 22.53% | 17.33% | |||
| INCY | INCYTE CORP | $19.39B | $97.08 | $108.39 | 11.65% | Buy | 13 | 7.51% | 11.32% | 13.39% | 10.26% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $1.81B | $17.12 | $26.33 | 53.81% | Hold | 6 | -14.05% | 7.14% | 18.40% | 8.71% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.